Skip to content
Recall Observatory FDA recall evidence

Drug product

Gildess 24 FE 1.5/30 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 count, (a) 3 blisters (NDC 0603-7610-49), and (b) 6 blisters (NDC 0603-7610-17), Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL 35811

D-0123-2017

September 27, 2016

Class III

Product summary

Firm
Par Pharmaceutical, Inc.
Event
Event 75455
Status
Completed
Classification
Class III
Quantity
44,127 tablets
Official record key
drug-enforcement:D-0123-2017

Official wording

Reason: Subpotent Drug; Ethinyl Estradiol

Code information: Lot Numbers (a) 4082018, 4082019, 4359320, 4461688, 4501285, 4501286 (b) 4028921, 4258629, 4359321, 4461689, 4501287, 4581736

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent